Multidisciplinary clinical guidelines in proactive monitoring, early diagnosis, and effective management of trastuzumab deruxtecan (T-DXd)-induced interstitial lung disease (ILD) in breast cancer patients.
ESMO Open
; 8(6): 102043, 2023 Dec.
Article
in En
| MEDLINE
| ID: mdl-37951130
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Lung Diseases, Interstitial
/
Immunoconjugates
Limits:
Female
/
Humans
Language:
En
Journal:
ESMO Open
Year:
2023
Document type:
Article
Country of publication: